• Press Release

Icahn School of Medicine at Mount Sinai Welcomes New Chief of Clinical Immunology

  • New York, NY
  • (October 31, 2019)

Rachel L. Miller, MD, FAAAAI, an expert in asthma and allergies, has been appointed as Chief of Clinical Immunology at the Icahn School of Medicine at Mount Sinai.

Dr. Miller joins the Icahn School of Medicine from the Vagelos College of Physicians and Surgeons at Columbia University, where she was Professor of Medicine (in Pediatrics) and Environmental Health Sciences and Division Chief for Pediatric Allergy, Immunology, and Rheumatology. Additionally, Dr. Miller served as Director of Adult Allergy, Director of the Allergy and Immunology Fellowship program, and Director of the Columbia University Medical Center and NewYork-Presbyterian/Morgan Stanley Children’s Hospital Food Allergy Research and Education Clinical Network.

“We are beyond thrilled to welcome Dr. Miller, who I’m sure will be a tremendous asset to our system and to the patients we serve, many of whom struggle with asthma and other environmental allergens that are common in an urban setting such as New York,” says Barbara Murphy, MD, Murray M. Rosenberg Professor of Medicine and Dean, Clinical Integration and Population Health, Icahn School of Medicine at Mount Sinai.

Dr. Miller’s research is primarily focused on the mechanisms underlying the onset of asthma. This includes investigating the role that environmental allergens, traffic-related pollutants, and phthalate and bisphenol exposure play in the onset of both allergies and asthma. Additionally, she has investigated environmental epigenetic regulation and the role of prenatal and early childhood exposure in later pediatric and adolescent asthma risk.

“I am very excited and honored to have joined the Mount Sinai Health System; it is an outstanding institution filled with exceptional talent,” says Dr. Miller.

Dr. Miller is the deputy editor of The Journal of Allergy and Clinical Immunology. She is a member of several professional societies including the American Thoracic Society; the American Academy of Allergy, Asthma, and Immunology; and the Assembly on Allergy, Immunology, and Inflammation of the American Thoracic Society.

Dr. Miller earned her medical degree at New York University School of Medicine. She completed an internship and residency in the Department of Medicine at Columbia University Medical Center as well as postdoctoral fellowships in pulmonary and critical care medicine and allergy and immunology.


About the Mount Sinai Health System

Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.

As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.

Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.